Revised SPC: Vibramycin-D (doxycycline) Dispersible Tablets 100mg

SPC updated with an addition of a warning regarding risk of exacerbating systemic lupus erythematous and undesirable effects of visual disturbances and link to cranial hypertension.

Source:

electronic Medicines compendium